Consolidating the mission to defeat aging: A big step forward

Rejuvenation Research

Volumn 11, Issue 6, 2008, Pages 1061-1063

  De Grey, Aubrey D N J ^a  

^a Methuselah Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL AGING; CELL PROTECTION; CONFERENCE PAPER; DNA DAMAGE; GERONTOLOGY; HEALTH CARE POLICY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REJUVENATION; SENESCENCE; TELOMERE;

AGING; ANIMALS; HUMANS; REGENERATION; TISSUE ENGINEERING;

EID: 58149229541     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0826     Document Type: Conference Paper

References (52)

1. Heward CB. Negligible senescence: how will we know it when we see it? Rejuvenation Res 2006;9:362-366.
2. Breitenbach M, Wolbert W, Weiss AM. The ongoing debate in EMBO reports concerning the SENS program. Rejuvenation Res 2006;9:494-495.
3. Warner HR. Scientific and ethical concerns regarding engineering human longevity. Rejuvenation Res 2006;9:440-442.
4. de Grey ADNJ. Is SENS a farrago? Rejuvenation Res 2006;9:436-439.
5. Johnson TE. Description of the 2005 meeting of the special interest group on Societal Implications of Anti-Aging Research at the Gerontological Society of America. Rejuvenation Res 2006;9:431-432.
6. de Grey ADNJ. Might the biogerontological impact of nonspecific nDNA damage be slight? Rejuvenation Res 2007;10:S26.
7. Binstock RH, Fishman JR, Juengst ET. Boundaries and labels: anti-aging medicine and science. Rejuvenation Res 2006;9:433-435.
8. de Grey ADNJ. The case for prioritizing research on late-onset life-extension interventions in mammals. Rejuvenation Res 2007;10:257-259.
9. de Grey ADNJ. Understanding and tackling aging: two fields communicating (a little) at last. Rejuvenation Res 2007;10:637-640.
10. Farrelly C. Sufficiency, justice, and the pursuit of health extension. Rejuvenation Res 2007;10:513-520.
11. Stock G, Callahan D. Debate: the effects of life extension. Rejuvenation Res 2007;10:407-416.
12. Wilkes R. SENS: an engineer's point of view on feasibility and bioethics dialogue. Rejuvenation Res 2007;10:235-236.
13. Harris J. Interview with John Harris. Interview by Vicki Glaser. Rejuvenation Res 2007;10:107-111.
14. de Grey ADNJ. Aging and airborne HIV: a reassuring analogy. Rejuvenation Res 2007;10:1-3.
15. de Grey ADNJ. Has Hippocrates had his day? Rejuvenation Res 2006;9:371-373.
16. de Grey ADNJ. Compression of morbidity: the hype and the reality, part 2. Rejuvenation Res 2006;9:167-168.
17. de Grey ADNJ. Compression of morbidity: the hype and the reality, part 1. Rejuvenation Res 2006;9:1-2.
18. Bains WA. Can I have volunteers to die tomorrow? Rejuvenation Res 2007;10:648-650.
19. Hodes RJ. National Institute on Aging. Interview by Vicki Glaser. Rejuvenation Res 2006;9:419-422.
20. de Grey ADNJ. SENS survives the challenge: now let's get to work. Rejuvenation Res 2006;9:429-430.
21. Abramovich A, Fraifeld V. Have we reached the point for in vivo rejuvenation? Rejuvenation Res 2007;10:S19.
22. Warner HR. Making the political case for biogerontology funding: a view from the trenches. Rejuvenation Res 2007;10:S51.
23. Powers LF. Pots of gold in anti-aging regenerative medicine? Rejuvenation Res 2007;10:S46.
24. Stelzner M, Chen DC. To make a new intestinal mucosa. Rejuvenation Res 2006;9:20-25.
25. Heber-Katz E, Leferovich J, Bedelbaeva K, Gourevitch D, Clark L. Conjecture: Can continuous regeneration lead to immortality? Studies in the MRL mouse. Rejuvenation Res 2006;9:3-9.
26. Gardiner DM, Satoh A, Ferris D, Graham G, Bryant SV, Rugg E. Engineering a blastema: steps toward regenerating a limb. Rejuvenation Res 2007;10:S31.
27. Virts EL, Phillips JA, Thoman ML. A novel approach to thymic rejuvenation in the aged. Rejuvenation Res 2006;9:134-142.
28. Conboy I, Carlson M, O'Connor M, Conboy MJ. Will stem cell-based tissue replacement work in the old? Rejuvenation Res 2007;10:S24.
29. Stolzing A, Hescheler J, Sethe S. Fusion and regenerative therapies: is immortality really recessive? Rejuvenation Res 2007;10:571-586.
30. Ellis-Behnke RG, Liang YX, Tay DKC, Schneider GE, So KF. Using nanotechnology to repair the body. Rejuvenation Res 2007;10:S28.
31. Emsley JG. Stimulating neurogenesis in "non-neurogenic" brain regions. Rejuvenation Res 2007;10:S28.
32. Fathi F, A. Kermani AJ, Pirmoradi L, Mowla SJ, Asahara T. Angiogenesis in vitro: vascular tube formation from the differentiation of murine embryonic stem cells. Rejuvenation Res 2007;10:S29.
33. Larrick JW, Huang M, Lum L, Lee R. Specific targeting of therapeutic stem cells for cardiovascular disease. Rejuvenation Res 2007;10:S37.
34. Tallen G, Soliman MA, Riabowol K. The cancer-aging interface and the significance of telomere dynamics in cancer therapy. Rejuvenation Res 2007;10:387-395.
35. Siddiqa A, Cavazos DA, Marciniak RA. Targeting telomerase. Rejuvenation Res 2006;9:378-390.
36. Flanary BE, Kletetschka G. Analysis of telomere length and telomerase activity in tree species of various lifespans, and with age in the bristlecone pine Pinus longaeva. Rejuvenation Res 2006;9:61-63.
37. Berger W. ALTernative ways to immortality: blessing or curse? Rejuvenation Res 2007;10:S20.
38. Effros RB. Telomerase-based approaches to enhance immunity to viruses during ageing. Rejuvenation Res 2007;10:S27-S28.
39. Kuznetsova IS, Voronin AP, Podgornaya OI. Telomere and TRF2/MTBP localization in respect to satellite DNA during the cell cycle of mouse cell line L929. Rejuvenation Res 2006;9:391-401.
40. Han X, Berardi P, Riabowol K. Chromatin modification and senescence: linkage by tumor suppressors? Rejuvenation Res 2006;9:69-76.
41. Stolzing A, Coleman N, Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 2006;9:31-35.
42. Gravekamp C, Castro F, Kim SH. Efficacy of cancer vaccines to prevent cancer in the elderly. Rejuvenation Res 2007;10:S32.
43. Candore G, Colonna-Romano G, Balistreri CR, Di Carlo D, Grimaldi MP, Listì F, Nuzzo D, Vasto S, Lio D, Caruso C. Biology of longevity: role of the innate immune system. Rejuvenation Res 2006;9:143-148.
44. Pawelec G, Koch S, Gouttefangeas C, Wikby A. Immunorejuvenation in the elderly. Rejuvenation Res 2006;9:111-116.
45. Akbar A. Retarding immune senescence and reducing infections in ageing. Rejuvenation Res 2007;10:S19.
46. Bulati M, Colonna-Romano C, Aquino A, Vitello S, Ventura C, Lio D, Candore G, Caruso C. Regulatory T cells in frail elderly. Rejuvenation Res 2007;10:S21-S22.
47. Candore G, Vasto S, Balistreri CR, Listi F, Grimaldi MP, Colonna-Romano G, Scola L, Lio D, Caruso C. Immunosenescence and anti-immunosenescence therapies in ageing. Rejuvenation Res 2007;10:S23.
48. Hawkins RE. Engineering anti-cancer T cells. Rejuvenation Res 2007;10:S33.
49. Cui Z, Molnar I, Willingham MC, Pomper GJ, Stehle JR, Blanks M. From a newly discovered innate anticancer immune response in mice to a new treatment for human cancers. Rejuvenation Res 2007;10:S25-S26.
50. Siegel B. Genetics Policy Institute. Interview by Vicki Glaser. Rejuvenation Res 2006;9(4):496-502.
51. Siegel B. The inevitable legal battle over engineered negligible senescence. Rejuvenation Res 2007;10:S48.
52. Glenn PF, Collins MR. The Glenn Foundation for Medical Research, Santa Barbara, CA: interview with Paul F. Glenn and Mark R. Collins. Interview by Vicki Glaser. Rejuvenation Res 2007;10:651-656.